scispace - formally typeset
J

Jing Hu

Researcher at University of California, San Diego

Publications -  25
Citations -  1613

Jing Hu is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Histone code & Chromatin immunoprecipitation. The author has an hindex of 16, co-authored 24 publications receiving 1186 citations. Previous affiliations of Jing Hu include Wuhan University & University of Electronic Science and Technology of China.

Papers
More filters
Journal ArticleDOI

Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice.

TL;DR: In this article, the authors adopted a stenosis model of deep vein thrombosis and analyzed venous thrombi in peptidylarginine deiminase 4 (PAD4)-deficient mice that cannot citrullinate histones, a process required for chromatin decondensation and NET formation.
Journal ArticleDOI

Reversing a model of Parkinson’s disease with in situ converted nigral neurons

TL;DR: An efficient one-step conversion of isolated mouse and human astrocytes to functional neurons by depleting the RNA-binding protein PTB is reported, identifying a potentially powerful and clinically feasible approach to treating neurodegeneration by replacing lost neurons.
Journal ArticleDOI

The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations

TL;DR: It is demonstrated that enhanced R-loops, opposite to the expectation from gained RNA binding with mutant SRSF2, result from impaired transcription pause release because the mutant protein loses its ability to extract the RNA polymerase II C-terminal domain (CTD) kinase-the positive transcription elongation factor complex (P-TEFb)-from the 7SK complex.
Journal ArticleDOI

Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity

TL;DR: PAD4 regulates the mTORC1 signaling pathway and that PAD inhibitors are potential anticancer reagents that activate tumor suppressor gene expression alone or in combination with histone deacetylase inhibitors.
Journal ArticleDOI

Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells

TL;DR: It is reported that the functionality requires sequential inactivation of PTB and the PTB paralog nPTB in HAFs, and suggests that two separate gatekeepers control neuronal conversion and maturation and consecutively overcoming these gatekeepers enables deterministic reprogramming of H AFs into functional neurons.